Yet Lillys sales growth suggests a quickly closing gap, with Mounjaros 71% quarterly growth and Zepbounds 140% quarterly increase
Yes, tirzepatide (Mounjaro, Zepbound) can cause nausea and vomiting, which are among the most common side effects of this dual GIP and GLP-1 receptor agonist
It works through a satiety pathway that is distinct from, and complementary to, GLP-1, which is why it is widely studied both alone and stacked with GLP-1 agonists
Most workouts cant protect your muscle on GLP-1s this one does
Therefore, individuals considering Semaglutide for weight loss should discuss their goals and expectations with a healthcare provider to develop a personalized treatment plan that aligns with their needs and preferences
This article is for general educational purposes and is not medical advice or a prescription